The NF-κB pathway has been recognized as a key player in CRC progression, being involved in the EMT process [28, 29]; therefore, we evaluated the effect of the CYTOR-NCL-Sam68 complex on the NF-κB signaling pathway. The gene discussed is NUCLEOLIN; the disease is colorectal carcinoma.